KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Novavax (NVAX) over the last 12 years, with Sep 2025 value amounting to $1.1 billion.

  • Novavax's Total Non-Current Liabilities fell 44.11% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 44.11%. This contributed to the annual value of $1.8 billion for FY2024, which is 26.46% down from last year.
  • Novavax's Total Non-Current Liabilities amounted to $1.1 billion in Q3 2025, which was up 6.10% from $1.0 billion recorded in Q2 2025.
  • Novavax's 5-year Total Non-Current Liabilities high stood at $3.0 billion for Q2 2022, and its period low was $1.0 billion during Q2 2025.
  • For the 3-year period, Novavax's Total Non-Current Liabilities averaged around $1.8 billion, with its median value being $1.9 billion (2024).
  • As far as peak fluctuations go, Novavax's Total Non-Current Liabilities skyrocketed by 351.93% in 2021, and later plummeted by 47.19% in 2025.
  • Over the past 5 years, Novavax's Total Non-Current Liabilities (Quarterly) stood at $2.9 billion in 2021, then declined by 1.71% to $2.8 billion in 2022, then declined by 12.54% to $2.5 billion in 2023, then fell by 26.46% to $1.8 billion in 2024, then crashed by 44.11% to $1.1 billion in 2025.
  • Its Total Non-Current Liabilities was $1.1 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.1 billion in Q1 2025.